The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gonella Jacques since 2012.
The trader's CIK number is 1189296.
At the time of the last reporting, Gonella Jacques was the Director of Antares Pharma, Inc.. (stock ticker symbol ATRS).
Also see all insider trading activities at Antares Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ATRS | 0 | $0 | 200,000 | $730,000 | 0 | $0 |
| 2018 | ATRS | 0 | $0 | 2,500,565 | $7,029,139 | 30,000 | $25,500 |
| 2017 | ATRS | 0 | $0 | 0 | $0 | 30,000 | $49,500 |
| 2016 | ATRS | 100,000 | $72,000 | 0 | $0 | 0 | $0 |
| 2015 | ATRS | 0 | $0 | 0 | $0 | 40,000 | $58,800 |
| 2014 | ATRS | 0 | $0 | 0 | $0 | 11,500 | $12,627 |
| 2013 | ATRS | 0 | $0 | 0 | $0 | 28,000 | $32,564 |
| 2012 | ATRS | 0 | $0 | 0 | $0 | 5,000 | $7,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-26 | ATRS | Sale | 200,000 | 3.65 | 730,000 |
| 2018-10-02 | ATRS | Sale | 400,000 | 3.79 | 1,516,000 |
| 2018-08-13 | ATRS | Sale | 49,507 | 3.09 | 152,976 |
| 2018-08-08 | ATRS | Sale | 250,493 | 3.09 | 774,023 |
| 2018-06-15 | ATRS | Sale | 565 | 2.95 | 1,666 |
| 2018-06-12 | ATRS | Sale | 100,000 | 2.77 | 277,000 |
| 2018-06-11 | ATRS | Sale | 100,000 | 2.69 | 269,000 |
| 2018-06-06 | ATRS | Sale | 20,259 | 2.70 | 54,699 |
| 2018-06-05 | ATRS | Sale | 23,129 | 2.70 | 62,448 |
| 2018-06-01 | ATRS | Sale | 56,612 | 2.70 | 152,852 |
| 2018-06-04 | ATRS | Sale | 100,000 | 2.65 | 265,000 |
| 2018-06-05 | ATRS | Sale | 100,000 | 2.55 | 254,999 |
| 2018-06-01 | ATRS | Sale | 78,938 | 2.60 | 205,238 |
| 2018-05-30 | ATRS | Sale | 100,000 | 2.55 | 254,999 |
| 2018-05-22 | ATRS | Sale | 5,318 | 2.53 | 13,454 |
| 2018-05-23 | ATRS | Sale | 194,682 | 2.52 | 489,625 |
| 2018-05-18 | ATRS | Sale | 21,062 | 2.60 | 54,761 |
| 2018-05-16 | ATRS | Sale | 100,000 | 2.52 | 252,000 |
| 2018-05-17 | ATRS | Sale | 100,000 | 2.55 | 254,999 |
| 2018-05-15 | ATRS | Sale | 100,000 | 2.50 | 250,000 |
| 2018-05-14 | ATRS | Sale | 100,000 | 2.50 | 250,000 |
| 2018-05-10 | ATRS | Sale | 100,000 | 2.36 | 236,000 |
| 2018-05-11 | ATRS | Sale | 100,000 | 2.47 | 247,000 |
| 2018-05-09 | ATRS | Sale | 300,000 | 2.47 | 740,400 |
| 2018-05-03 | ATRS | Option Ex | 30,000 | .85 | 25,500 |
| 2017-03-31 | ATRS | Option Ex | 30,000 | 1.65 | 49,500 |
| 2016-03-18 | ATRS | Buy | 100,000 | .72 | 72,000 |
| 2015-12-16 | ATRS | Option Ex | 20,000 | 1.54 | 30,800 |
| 2014-12-30 | ATRS | Option Ex | 20,000 | 1.40 | 28,000 |
| 2014-01-14 | ATRS | Option Ex | 11,500 | 1.10 | 12,627 |
| 2013-10-07 | ATRS | Option Ex | 28,000 | 1.16 | 32,564 |
| 2012-12-11 | ATRS | Option Ex | 5,000 | 1.50 | 7,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gonella Jacques (Director of Antares Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.